Be specific in your intake form about your history: which medication, at what dose, for how long, and why you stopped or switched, if applicable
In the Phase 1 b trial of diabetic subjects, LY3298176 doses of 10 mg and 15 mg significantly reduced fasting serum glucose compared to placebo (least square mean [LSM] difference [95% CI]: -49.12 mg/dL [-78.14, -20.12] and -43.15 mg/dL [-73.06, -13.21], respectively)
But the biology changes long before those typical labs move
A tetrasubstituted 29-amino acid peptide analog of Growth Hormone Releasing Hormone (GHRH)
On the basis of novel data and hypothesis on the possible role of scarce glutathione (GSH) levels in the exacerbation of COVID-19 and of the GSH depleting activity of PAC, this commentary raises the question of whether PAC may be the better choice